0

European Antibiotics Market Expected to Reach $13.52 Billion by 2027

 
2022
European Antibiotics Market

Report Code : A10311

quote “the growth of the European Antibiotics Market is driven by increase in prevalence of infectious diseases and rise in development of generic drugs in the European region that further drive the market growth.” quote

According to Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “European Antibiotics Market by Drug Class, Drug Origin, Spectrum of Activityand Route of Administration: Opportunity Analysis and Industry Forecast, 2019-2027,”

The European antibiotics market size was valued at $11,561million in 2019, and is projected to reach $13,529million by 2027 at a CAGR of 1.9% from 2020 to 2027. 

Antibiotics are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit the growth of bacteria and protozoans. The antibiotics market is expected to exhibit significant growth during the forecast period due to rise in prevalence of infectious diseases. In addition, development of novel approaches for new antibiotics for treating bacterial infections and a large number of clinical trials, further supplements the European antibioticsmarket growth.

Europe has been massively hit by COVID-19 outbreak affecting many of its countries on a large scale. Italy, Germany, Spain, the UK, and France along with other European countries are witnessing rise in number of COVID-19 cases every day. This pandemic is expected to present growth opportunities for European antibiotics in the future. It is imperative to be aware of the unreported amounts of antibiotics that have been administered in just a few months and a marked increase in antimicrobial resistance should therefore be expected.Information on antimicrobial treatments given to patients with SARS-CoV-2 infection is rareThe antibiotics used were cephalosporins, quinolones, carbapenems, tigecycline (against MRSA) and linezolid.Other antibiotic therapeutics proposed for the treatment of COVID-19 disease are azithromycin, quercetin, rapamycin and doxycycline. However, the combination of hydroxychloroquine (an analogue of chloroquine considered an old antimalarial drug) and azithromycin appeared to be even more effective in COVID-19 treatment.17 Azithromycin also inhibits the replication of other viruses, such as Zika and Ebola. Azithromycin, doxycycline and rapamycin are antibiotic drugs that inhibit protein synthesis and functionally reduce inflammation and viral replication.

By class, the European antibioticsmarket is segmented into beta lactam & beta lactamase inhibitors, quinolones, macrolides, and others. The beta lactam & beta lactamase inhibitors segment was the major revenue contributor in 2019, and is anticipated to continue this trend during the forecast period due to its spectrum of activity. These antibiotics are a class of broad-spectrum antibiotics. A broad-spectrum antibiotic acts against both Gram-positive & Gram-negative bacteria and effective on the infections with multiple groups of bacteria. Thus, the demand for beta lactam &beta lactamase inhibitors antibiotics is high. On the other side, the demand for quinolones is projected to exhibit the fastest market growth during the forecast period owing to the rise in demand of broad-spectrum bactericidal activity new generation quinolones, excellent oral bioavailability, good tissue penetration, and better safety & tolerability.

By drug origin, the market is categorized into natural, semisynthetic, and synthetic. The semisynthetic function presently dominates the European antibioticsmarket, and is expected to remain dominant during the forecast period. This is attributed to the fact that the semisynthetic antibiotics have improved coverage and effectiveness against a wide range of organisms. Also, the semisynthetic antibiotics can be administered either parenterally or orally as well as less costly to administer than other antibiotics in some cases. However, the synthetic segment is projected to show fastest growth during the forecast period, due to the rising need of synthetic membrane-targeted antibiotics due to the antimicrobial resistance. The synthetic antibiotics have various advantages over existing antibiotics such as a broad spectrum of activity, no cross-resistance with the existing antibiotics, rapid bactericidal activity, and a low probability for developing resistance.

The key companies profiled in the report includeAbbott Laboratories, Abbvie (Allergan Plc.), Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co. Inc.,Viatris Inc., Novartis International AG (Sandoz), Pfizer Inc.,and Sanofi. 

KEY FINDINGS OF THE STUDY

  • Byspectrum of activity, the broad-spectrum antibiotic segment is expected to experience rapid growth in the European antibioticsmarket, and is projected to grow at a CAGR of 75.5% from 2020 to 2027.
  • Byroute of administration, the intravenous segment held more than half of the European antibioticsmarket share in 2019, and is expected to remain dominant throughout the forecast period. 
  • Bydrug class, the beta lactam and beta lactamase inhibitorssegment occupied 55.7% share of the European antibiotics market in 2019.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote European Antibiotics Market by Drug Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, and Others), Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic and Narrow-spectrum Antibiotic), and Route of Administration (Oral, Intravenous, and Others): Opportunity Analysis and Industry Forecast, 2019–2027 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Mar 2024

Hairbrush Market

Download Sample
rep-img

Published Date Mar 2024

Debt Security Market

Download Sample
rep-img

Published Date Mar 2024

Wood Adhesives Market

Download Sample

Buy Full Version
"European Antibiotics Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers